Forskning ved Københavns Universitet - Københavns Universitet

Forside

Identification of ADAM12 as a Novel Basigin Sheddase

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Identification of ADAM12 as a Novel Basigin Sheddase. / Albrechtsen, Reidar; Wewer Albrechtsen, Nicolai J; Gnosa, Sebastian; Schwarz, Jeanette; Dyrskjøt, Lars; Kveiborg, Marie.

I: International Journal of Molecular Sciences , Bind 20, Nr. 8, 1957 , 2019.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Albrechtsen, R, Wewer Albrechtsen, NJ, Gnosa, S, Schwarz, J, Dyrskjøt, L & Kveiborg, M 2019, 'Identification of ADAM12 as a Novel Basigin Sheddase', International Journal of Molecular Sciences , bind 20, nr. 8, 1957 . https://doi.org/10.3390/ijms20081957

APA

Albrechtsen, R., Wewer Albrechtsen, N. J., Gnosa, S., Schwarz, J., Dyrskjøt, L., & Kveiborg, M. (2019). Identification of ADAM12 as a Novel Basigin Sheddase. International Journal of Molecular Sciences , 20(8), [1957 ]. https://doi.org/10.3390/ijms20081957

Vancouver

Albrechtsen R, Wewer Albrechtsen NJ, Gnosa S, Schwarz J, Dyrskjøt L, Kveiborg M. Identification of ADAM12 as a Novel Basigin Sheddase. International Journal of Molecular Sciences . 2019;20(8). 1957 . https://doi.org/10.3390/ijms20081957

Author

Albrechtsen, Reidar ; Wewer Albrechtsen, Nicolai J ; Gnosa, Sebastian ; Schwarz, Jeanette ; Dyrskjøt, Lars ; Kveiborg, Marie. / Identification of ADAM12 as a Novel Basigin Sheddase. I: International Journal of Molecular Sciences . 2019 ; Bind 20, Nr. 8.

Bibtex

@article{c0ada07568a04337aea7c6991c0a6a30,
title = "Identification of ADAM12 as a Novel Basigin Sheddase",
abstract = "The transmembrane glycoprotein basigin, a member of the immunoglobulin superfamily, stimulates matrix metalloproteinase (MMP)-mediated extracellular matrix (ECM) degradation and thereby drives cancer cell invasion. Basigin is proteolytically shed from the cell surface and high concentrations of soluble basigin in the blood dictates poor prognosis in cancer patients. A positive correlation between basigin and a disintegrin and metalloproteinase (ADAM)-12 in serum from prostate cancer patients has been reported. Yet, the functional relevance of this correlation is unknown. Here, we show that ADAM12 interacts with basigin and cleaves it in the juxtamembrane region. Specifically, overexpression of ADAM12 increases ectodomain shedding of an alkaline phosphatase-tagged basigin reporter protein from the cell surface. Moreover, CRISPR/Cas9-mediated knockout of ADAM12 in human HeLa carcinoma cells results in reduced shedding of the basigin reporter, which can be rescued by ADAM12 re-expression. We detected endogenous basigin fragments, corresponding to the expected size of the ADAM12-generated ectodomain, in conditioned media from ADAM12 expressing cancer cell-lines, as well as serum samples from a healthy pregnant donor and five bladder cancer patients, known to contain high ADAM12 levels. Supporting the cancer relevance of our findings, we identified several cancer-associated mutations in the basigin membrane proximal region. Subsequent in vitro expression showed that some of these mutants are more prone to ADAM12-mediated shedding and that the shed ectodomain can enhance gelatin degradation by cancer cells. In conclusion, we identified ADAM12 as a novel basigin sheddase with a potential implication in cancer.",
author = "Reidar Albrechtsen and {Wewer Albrechtsen}, {Nicolai J} and Sebastian Gnosa and Jeanette Schwarz and Lars Dyrskj{\o}t and Marie Kveiborg",
year = "2019",
doi = "10.3390/ijms20081957",
language = "English",
volume = "20",
journal = "International Journal of Molecular Sciences (Online)",
issn = "1661-6596",
publisher = "MDPI AG",
number = "8",

}

RIS

TY - JOUR

T1 - Identification of ADAM12 as a Novel Basigin Sheddase

AU - Albrechtsen, Reidar

AU - Wewer Albrechtsen, Nicolai J

AU - Gnosa, Sebastian

AU - Schwarz, Jeanette

AU - Dyrskjøt, Lars

AU - Kveiborg, Marie

PY - 2019

Y1 - 2019

N2 - The transmembrane glycoprotein basigin, a member of the immunoglobulin superfamily, stimulates matrix metalloproteinase (MMP)-mediated extracellular matrix (ECM) degradation and thereby drives cancer cell invasion. Basigin is proteolytically shed from the cell surface and high concentrations of soluble basigin in the blood dictates poor prognosis in cancer patients. A positive correlation between basigin and a disintegrin and metalloproteinase (ADAM)-12 in serum from prostate cancer patients has been reported. Yet, the functional relevance of this correlation is unknown. Here, we show that ADAM12 interacts with basigin and cleaves it in the juxtamembrane region. Specifically, overexpression of ADAM12 increases ectodomain shedding of an alkaline phosphatase-tagged basigin reporter protein from the cell surface. Moreover, CRISPR/Cas9-mediated knockout of ADAM12 in human HeLa carcinoma cells results in reduced shedding of the basigin reporter, which can be rescued by ADAM12 re-expression. We detected endogenous basigin fragments, corresponding to the expected size of the ADAM12-generated ectodomain, in conditioned media from ADAM12 expressing cancer cell-lines, as well as serum samples from a healthy pregnant donor and five bladder cancer patients, known to contain high ADAM12 levels. Supporting the cancer relevance of our findings, we identified several cancer-associated mutations in the basigin membrane proximal region. Subsequent in vitro expression showed that some of these mutants are more prone to ADAM12-mediated shedding and that the shed ectodomain can enhance gelatin degradation by cancer cells. In conclusion, we identified ADAM12 as a novel basigin sheddase with a potential implication in cancer.

AB - The transmembrane glycoprotein basigin, a member of the immunoglobulin superfamily, stimulates matrix metalloproteinase (MMP)-mediated extracellular matrix (ECM) degradation and thereby drives cancer cell invasion. Basigin is proteolytically shed from the cell surface and high concentrations of soluble basigin in the blood dictates poor prognosis in cancer patients. A positive correlation between basigin and a disintegrin and metalloproteinase (ADAM)-12 in serum from prostate cancer patients has been reported. Yet, the functional relevance of this correlation is unknown. Here, we show that ADAM12 interacts with basigin and cleaves it in the juxtamembrane region. Specifically, overexpression of ADAM12 increases ectodomain shedding of an alkaline phosphatase-tagged basigin reporter protein from the cell surface. Moreover, CRISPR/Cas9-mediated knockout of ADAM12 in human HeLa carcinoma cells results in reduced shedding of the basigin reporter, which can be rescued by ADAM12 re-expression. We detected endogenous basigin fragments, corresponding to the expected size of the ADAM12-generated ectodomain, in conditioned media from ADAM12 expressing cancer cell-lines, as well as serum samples from a healthy pregnant donor and five bladder cancer patients, known to contain high ADAM12 levels. Supporting the cancer relevance of our findings, we identified several cancer-associated mutations in the basigin membrane proximal region. Subsequent in vitro expression showed that some of these mutants are more prone to ADAM12-mediated shedding and that the shed ectodomain can enhance gelatin degradation by cancer cells. In conclusion, we identified ADAM12 as a novel basigin sheddase with a potential implication in cancer.

U2 - 10.3390/ijms20081957

DO - 10.3390/ijms20081957

M3 - Journal article

C2 - 31013576

VL - 20

JO - International Journal of Molecular Sciences (Online)

JF - International Journal of Molecular Sciences (Online)

SN - 1661-6596

IS - 8

M1 - 1957

ER -

ID: 217337318